Island Pharmaceuticals Ltd has released a press release.
Prospectus
Filed with ASX ·
On 6ix: 6ix.com/news/prospectus-33
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Island Pharmaceuticals
- $1.95million Fully Underwritten Rights Issue
- Island investor presentation
- Dosing complete in ISLA-101 SAD study
- Quarterly Activity Report and Appendix 4C
- Third cohort dosed in ISLA-101 Single Ascending Dose study
Later from Island Pharmaceuticals
- Island Pharmaceuticals to raise $1.95 million for ISLA-101 development
- Security Class Suspension from Quotation ILAO
- Security Class Reinstatement to Quotation ILAO
- Positive data from ISLA-101 Single Ascending Dose study
- Investor Presentation - Asia Bio Partnering
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals